Results 71 to 80 of about 65,713 (156)

Tumor-associated CD8+T cell tolerance induced by erythroid progenitor cells

Frontiers in Immunology
IntroductionCD8+T cell tolerance plays an important role in tumor escape. Recent studies have shown that CD45+ erythroid progenitor cells (CD45+EPCs) generated through splenic extramedullary erythropoiesis suppress tumor immunity.
Xue Fan, Xue Fan, Xue Fan, Han Peng, Han Peng, Xuesong Wang, Xuesong Wang, Yixin Sun, Yixin Sun, Yan Dong, Yan Dong, Jie Zhou, Jie Zhou, Jianfang Chen, Jianfang Chen, Shuo Huang, Shuo Huang   +16 more
doaj   +1 more source

Adoptive cell transfer immunotherapy for patients with solid epithelial cancers. [PDF]

Cancer Cell, 2023
Rosenberg SA, Parkhurst MR, Robbins PF.
europepmc   +1 more source

T-lymphocytes from focused ultrasound ablation subsequently mediate cellular antitumor immunity after adoptive cell transfer immunotherapy. [PDF]

Front Immunol, 2023
Ran LF, Xie XP, Xia JZ, Xie FL, Fan YM, Wu F.   +5 more
europepmc   +1 more source

A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell transfer applications. [PDF]

Mol Ther Methods Clin Dev, 2023
Palianina D, Di Roberto RB, Castellanos-Rueda R, Schlatter F, Reddy ST, Khanna N.   +5 more
europepmc   +1 more source

Cell-intrinsic PD-L1 ablation sustains effector CD8+ T cell responses and promotes antitumor T cell therapy

Cell Reports
Summary: Adoptive cell therapies are emerging forms of immunotherapy that reprogram T cells for enhanced antitumor responses. Although surface programmed cell death-ligand 1 (PD-L1)/programmed cell death protein 1 (PD-1) engagement inhibits antitumor ...
Xinran Wang, Lu Lu, Xiaochuan Hong, Lingling Wu, Chao Yang, You Wang, Wenwen Li, Yuanqin Yang, Dongqing Cao, Wen Di, Liufu Deng   +10 more
doaj   +1 more source

Neoantigen Identification and Response to Adoptive Cell Transfer in Anti-PD-1 Naïve and Experienced Patients with Metastatic Melanoma. [PDF]

Clin Cancer Res, 2022
Levi ST, Copeland AR, Nah S, Crystal JS, Ivey GD, Lalani A, Jafferji M, White BS, Parikh NB, Leko V, Krishna S, Lowery F, Prickett TD, Gartner JJ, Jia L, Li YF, Sachs A, Sindiri S, Robinson W, Gasmi B, Yang JC, Goff SL, Rosenberg SA, Robbins PF.   +23 more
europepmc   +1 more source

Evaluation of the tumoricidal efficacy of adoptive cell transfer using hepatocellular carcinoma-derived organoids. [PDF]

J Gastrointest Oncol, 2022
Zhou Z, Yan X, Shi W, Tan K, Shao C, Wang Y, Wang G, Hong Y.   +7 more
europepmc   +1 more source

Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in Melanoma. [PDF]

Cancers (Basel), 2021
Lau PKH, Cullinane C, Jackson S, Walker R, Smith LK, Slater A, Kirby L, Patel RP, von Scheidt B, Slaney CY, McArthur GA, Sheppard KE.   +11 more
europepmc   +1 more source

Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer. [PDF]

Front Oncol, 2022
Fereydouni M, Motaghed M, Ahani E, Kafri T, Dellinger K, Metcalfe DD, Kepley CL.   +6 more
europepmc   +1 more source

Recovery of Latent HIV-1 from Brain Tissue by Adoptive Cell Transfer in Virally Suppressed Humanized Mice. [PDF]

J Neuroimmune Pharmacol, 2021
Su H, Sravanam S, Sillman B, Waight E, Makarov E, Mathews S, Poluektova LY, Gorantla S, Gendelman HE, Dash PK.   +9 more
europepmc   +1 more source